Bionomics Shares Outstanding 2022-2024 | NEUP
Bionomics shares outstanding from 2022 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Bionomics Annual Shares Outstanding
(Millions of Shares) |
| 2024 |
10 |
| 2023 |
8 |
| 2022 |
8 |
| 2021 |
4 |
Bionomics Quarterly Shares Outstanding
(Millions of Shares) |
| 2024-09-30 |
16 |
| 2024-06-30 |
|
| 2023-12-31 |
|
| 2023-09-30 |
8 |
| 2023-06-30 |
|
| 2022-12-31 |
|
| 2022-06-30 |
|
| 2021-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.010B |
$0.000B |
|
Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.
|
